Mesoblast

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Camarilla Pivot Points

Score

-0.95

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 114 4.0 0.42% 0.65% 3.5% -2.7% -31.5%
SHORT 115 4.3 0.46% 0.77% 2.8% -3.1% -68.9%

Summary

Technical Analysis

Mesoblast (MSB.AX)


Indicator:

CAMARILLA PIVOT POINT


Signal Strength: MEDIUM
Recommendation:

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading position.


Mesoblast (ASX:MSB) current pivot point Camarilla is: $1.785.

The current resistance levels are: (R1) $1.934
(R2) $2.083
(R3) $2.231
(R4) $2.678

The current support levels are: (S1) $1.636
(S2) $1.488
(S3) $1.339
(S4) $0.893



Camarilla pivot points were discovered in 1989 by Nick Scott, a successful bond trader. The basic thesis for this strategy is a common one: That price, as most time series, has a tendency to revert to its mean.

Calculation: Camarilla Pivot Points:
1) R4 = Close + (High – Low) * 1.1/2;
2) R3 = Close + (High – Low) * 1.1/4;
3) R2 = Close + (High – Low) * 1.1/6;
4) R1 = Close + (High – Low) * 1.1/12;
5) PP = (HIGH + LOW + CLOSE) / 3;
6) S1 = Close – (High – Low) * 1.1/12;
7) S2 = Close – (High – Low) * 1.1/6;
8) S3 = Close – (High – Low) * 1.1/4;
9) S4 = Close – (High – Low) * 1.1/2;


PROFILE: Mesoblast (MSB.AX)


Stock Exchange: ASX
Company: Mesoblast
Ticker Codes: | MSB.AX | ASX:MSB |

About Mesoblast (ASX:MSB):

Mesoblast Limited develops cell-based medicines. The company has leveraged its proprietary technology platform based on mesenchymal lineage adult stem cells to establish a portfolio of late-stage product candidates. Its allogeneic cell product candidates target advanced stages of diseases with high and unmet medical needs, including cardiovascular conditions, immunologic and inflammatory conditions, orthopedic disorders, and oncology and hematology conditions. The company's products under the Phase III clinical trials include MPC-150-IM for chronic and end-stage heart failure; MPC-06-ID for chronic low back pain; and MSC-100-IV for acute graft versus host disease in children. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, and diabetic kidney diseases and type 2 diabetes. The company has a collaboration agreement with JCR Pharmaceuticals Co., Ltd. It has operations in the United States, Australia, Singapore, and Switzerland. Mesoblast Limited was founded in 2004 and is headquartered in Melbourne, Australia.

Top 10:

Camarilla Pivot Points

Download
Company Close Change(%) Volume Value Signal
TNE Technology One 8.72 11.1 2,344,237 -0.02 BEARISH CROSSOVER
DNK Danakali 0.64 8.5 171,076 -0.03 BEARISH CROSSOVER
BSE BSE 0.24 6.8 118,988 -0.06 BEARISH CROSSOVER
CCV Cash Converters International 0.25 6.5 1,327,868 -0.02 BEARISH CROSSOVER
ALL Aristocrat Leisure 33.71 6 3,327,758 -0.01 BEARISH CROSSOVER
MLD Maca 1.07 5.9 822,651 -0.01 BEARISH CROSSOVER
ELX Ellex Medical Lasers 0.6 5.3 7,482 0 BEARISH CROSSOVER
IPD Impedimed 0.2 5.3 1,022,395 -0.03 BEARISH CROSSOVER
CDD Cardno 0.47 4.4 241,998 -0.03 BEARISH CROSSOVER
PPC Peet & Company 1.28 3.7 84,175 -0.01 BEARISH CROSSOVER